Hostname: page-component-7c8c6479df-fqc5m Total loading time: 0 Render date: 2024-03-27T08:08:55.935Z Has data issue: false hasContentIssue false

The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities

Published online by Cambridge University Press:  26 September 2018

Erika M. C. D’Agata*
Affiliation:
Division of Infectious Diseases, Rhode Island Hospital, Brown University, Providence, Rhode Island
Curt C. Lindberg
Affiliation:
Billings Clinic, Billings, Montana
Claire M. Lindberg
Affiliation:
Department of Nursing, The College of New Jersey, Ewing Township, New Jersey
Gemma Downham
Affiliation:
AtlantiCare Regional Medical Center, Pomona, New Jersey
Brandi Esposito
Affiliation:
AtlantiCare Regional Medical Center, Pomona, New Jersey
Douglas Shemin
Affiliation:
Division of Nephrology, Rhode Island Hospital, Brown University, Providence, Rhode Island
Sophia Rosen
Affiliation:
Fresenius Medical Care North America, Burlington, Massachusetts
*
Author for correspondence: Erika M.C. D’Agata MD, MPH, Division of Infectious Diseases, Brown University, 593 Eddy Street, Aldrich 720, Providence, RI. E-mail: edagata@lifespan.org

Abstract

Background

Antimicrobial stewardship programs are effective in optimizing antimicrobial prescribing patterns and decreasing the negative outcomes of antimicrobial exposure, including the emergence of multidrug-resistant organisms. In dialysis facilities, 30%–35% of antimicrobials are either not indicated or the type of antimicrobial is not optimal. Although antimicrobial stewardship programs are now implemented nationwide in hospital settings, programs specific to the maintenance dialysis facilities have not been developed.

Objective

To quantify the effect of an antimicrobial stewardship program in reducing antimicrobial prescribing.

Study design and setting

An interrupted time-series study in 6 outpatient hemodialysis facilities was conducted in which mean monthly antimicrobial doses per 100 patient months during the 12 months prior to the program were compared to those in the 12-month intervention period.

Results

Implementation of the antimicrobial stewardship program was associated with a 6% monthly reduction in antimicrobial doses per 100 patient months during the intervention period (P=.02). The initial mean of 22.6 antimicrobial doses per 100 patient months decreased to a mean of 10.5 antimicrobial doses per 100 patient months at the end of the intervention. There were no significant changes in antimicrobial use by type, including vancomycin. Antimicrobial adjustments were recommended for 30 of 145 antimicrobial courses (20.6%) for which there were sufficient clinical data. The most frequent reasons for adjustment included de-escalation from vancomycin to cefazolin for methicillin-susceptible Staphylococcus aureus infections and discontinuation of antimicrobials when criteria for presumed infection were not met.

Conclusions

Within 6 hemodialysis facilities, implementation of an antimicrobial stewardship was associated with a decline in antimicrobial prescribing with no negative effects.

Type
Original Article
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: D’Agata EMC, et al. (2018). The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities. Infection Control & Hospital Epidemiology 2018, 39, 1400–1405. doi: 10.1017/ice.2018.237

References

1. Karanika, S, Paudel, S, Grigoras, C, Kalbasi, A, Mylonakis, E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60:48404852.Google Scholar
2. Tamma, PD, Avdic, E, Li, DX, Dzintars, K, Cosgrove, SE. association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:13081315.Google Scholar
3. Zacharioudakis, IM, Zervou, FN, Ziakas, PD, Rice, LB, Mylonakis, E. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis 2015;65:8897.Google Scholar
4. Zacharioudakis, IM, Zervou, FN, Ziakas, PD, Mylonakis, E. Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients. J Am Soc Nephrol 2014;25:21312141.Google Scholar
5. Song, J., Park, HK, Kang, HK, Lee, J. Proposed risk factors for infection with multidrug-resistant pathogens in hemodialysis patients hospitalized with pneumonia. BMC Infect Dis 2017;17:681690.Google Scholar
6. Marston, HD, Dixon, DM, Knisely, JM, Palmore, TN, Fauci, AS. Antimicrobial resistance. JAMA 2016;316:11931204.Google Scholar
7. Core elements of hospital antibiotic stewardship programs. Centers for Disease Control and Prevention website. https://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html. Updated 2017. Accessed March 21, 2018.Google Scholar
8. Baur, D, Gladstone, BP, Burkert, F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:9901001.Google Scholar
9. Joint Commission Perspectives, July 2016, vol. 36, issue 7. Oakbrook Terrace, IL: The Joint Commission; 2016.Google Scholar
10. Snyder, GM, Patel, PR, Kallen, AJ, Strom, JA, Tucker, JK, D’Agata, EM. Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol. 2013;34:349357.Google Scholar
11. Hui, K, Nalder, M, Buising, K, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodilaysis: an observational study. BMC Nephrol 2017;18:156.Google Scholar
12. Snyder, G, Patel, PR, Kallen, AJ, Strom, JA, Tucker, JK, D’Agata, EMC. Factors associated with the receipt of antimicrobials among chronic hemodialysis patients. Am J Infect Control 2016;44:12691274.Google Scholar
13. Central line-associated bloodstream infection (CLABSI) event. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/TOC_PSCManual.html. Published 2012. Accessed August 25, 2018.Google Scholar
14. Clinical practice guidelines for vascular access. Am J Kidney Dis 006 2;48 Suppl 1:S176S247.Google Scholar
15. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48 Suppl 1:S248S273.Google Scholar
16. Nicolle, LE, Bradley, S, Colgan, R, Rice, JC, Schaeffer, A, Hooton, TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;9:643654.Google Scholar
17. Mandell, LA, Wunderink, RG, Anzueto, A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27S72.Google Scholar
18. Stevens, DL, Bisno, AL, Chambers, HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:13731406.Google Scholar
19. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44(RR-12):113.Google Scholar
20. High, KP, Bradley, SF, Gravenstein, S, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:149171.Google Scholar
21. Solomkin, JS, Mazuski, JE, Bradley, JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010;11:79109.Google Scholar
22. Anderson, DJ, Sexton, DJ.Overview of control measures to prevent surgical site infection. In: Harris A, ed. UpToDate. Waltham, MA: Wolters Kluwer Health; 2012.Google Scholar
23. Gupta, K, Hooton, TM, Naber, KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103e120.Google Scholar
24. Hooton, TM, Bradley, SF, Cardenas, DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625663.Google Scholar
25. Mackowiak, PA, Wasserman, SS, Levine, MM. A critical appraisal of 98.6°F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA 1992;268:15781580.Google Scholar
26. Dellinger, EP, Gross, PA, Barrett, TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994;18:422427.Google Scholar
27. Pascale, RS. The power of positive deviance: how unlikely innovators solve the world’s toughest problems. Boston: Harvard Business School Press. 2010.Google Scholar
28. Downham, G, Jones, E, Peterson, P, et al. Reducing bloodstream infections in an outpatient hemodialysis center—New Jersey, 20082011. Morb Mort Weekly Rep 2012;61:169173.Google Scholar
29. Lindberg, C, Downham, G, Buscell, P, Jones, E, Peterson, P, Krebs, V. Embracing collaboration: a novel strategy for reducing blood stream infections in outpatient dialysis centers. Am J Infect Control 2013:41:513519.Google Scholar
30. Schweizer, ML, Braun, BI, Milstone, AM. Research methods in healthcare epidemiology and antimicrobial stewardship-quasi-experimental designs. Infect Control Hosp Epidemiol 2016;37:11351140.Google Scholar
31. Wagner, AK, Soumerai, SB, Zhang, F, Ross-Degnan, D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2012;27:299330.Google Scholar
32. Schweizer, ML, Furuno, JP, Harris, AD et al. Comparative effectiveness of nafcillin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011;11:279286.Google Scholar
33. Stryjewski, ME, Szczech, LA, Benjamin, DK, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007;44:190196.Google Scholar
34. Chan, KE, Warren, HS, Thadhani, RI, et al. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol 2012;23:15511559.Google Scholar
35. Saely, S, Kaye, KS, Fairfax, MR, Chopra, T, Pogue, JM. Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase–producing Klebsiella pneumoniae . Am J Infect Control 2011;39:390395.Google Scholar
36. Cunha, CB, D’Agata, EMC. Antimicrobial stewardship in out-patient dialysis units. Curr Opin Nephrol Hypertens 2016;25:551555.Google Scholar
37. Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159177.Google Scholar
38. D’Agata, EMC. Addressing the problem of multidrug-resistant organisms in dialysis facilities. Clin J Amer Soc Nephrol 2018 (in press).Google Scholar